Back to top
more

Tilray Brands (TLRY)

(Real Time Quote from BATS)

$2.19 USD

2.19
54,606,152

+0.12 (5.80%)

Updated May 16, 2024 02:56 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (61 out of 250)

Industry: Consumer Products - Staples

Better trading starts here.

Zacks News

Ryan McQueeney headshot

Are There Any Dividend-Paying Cannabis Stocks?

Cannabis stocks have been one of the investing world's top stories in 2018, but for many, these speculative plays are far too unpredictable. Are there any stable, dividend-paying marijuana stocks to buy right now?

Tilray, Inc. (TLRY) Gains But Lags Market: What You Should Know

Tilray, Inc. (TLRY) closed the most recent trading day at $102.94, moving +0.48% from the previous trading session.

Options Traders Expect Huge Moves in Tilray (TLRY) Stock

Tilray (TLRY) needs investors to pay close attention to the stock based on moves in the options market lately.

Nitish Marwah headshot

Legal Pot Shops & Likely IPOs: Is Hemp the Next Big Thing?

Increasing tolerance and gradual legalization of marijuana has been an increasing trend across America.

Sanghamitra Saha headshot

Top and Flop ETFs of Last Week

Inside the winning and losing ETFs of the last week.

Sanghamitra Saha headshot

What Went Wrong With the Marijuana ETF on Wednesday?

Downbeat earnings have weighed on the marijuana ETF lately. Should you buy the dip or wait on the sidelines?

Ryan McQueeney headshot

Cannabis Stocks Reporting Earnings & News from HD, AAPL, TSN

Ryan McQueeney discusses the latest trade war developments and recaps earnings results from Home Depot and Tyson Foods. He also touches on Apple's supplier concerns. Later, the host chats with Dave Bartosiak about the marijuana stocks reporting earnings this week.

Cronos (CRON) to Report Q3 Earnings: What's in the Offing?

Cronos' (CRON) third-quarter results are likely benefit from the company's collaboration initiatives to become one of the most promising cannabis company.

Tilray (TLRY) to Report Q3 Earnings: What's in the Cards?

We expect investors to focus on Tilray's (TLRY) pipeline updates when it reports third-quarter results.

    Tracey Ryniec headshot

    The Earnings Charts of 3 Top Cannabis Stocks

    The cannabis stocks are hot but will their earnings reports be too?

    The Zacks Analyst Blog Highlights: Tilray, Walmart and NVIDIA

    The Zacks Analyst Blog Highlights: Tilray, Walmart and NVIDIA

    Ryan McQueeney headshot

    Upcoming Earnings to Watch: TLRY, WMT, NVDA

    U.S. stocks fell sharply in morning trading, as concerns about slumping oil prices, a hotter-than-expected PPI, and a more hawkish Fed cooled Wall Street's post-election bullishness. Investors will now turn to the last wave of Q3 earnings reports for clues on what is next for this market

    The Zacks Analyst Blog Highlights: Tilray, Canopy Growth, Cronos and ETFMG Alternative Harvest

    The Zacks Analyst Blog Highlights: Tilray, Canopy Growth, Cronos and ETFMG Alternative Harvest

    Neena Mishra headshot

    Why Marijuana Stocks & ETF Soared Today

    Pot stocks soared today as Jeff Sessions' exit and midterm elections have created a more favorable political environment for the industry.

    Cronos (CRON) to Report Q3 Earnings: What's in the Cards?

    Investors will focus on pipeline progress and updates when Cronos (CRON) reports third-quarter results.

    Tilray, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know

    Tilray, Inc. (TLRY) closed at $100.98 in the latest trading session, marking a +1.5% move from the prior day.

    Is A Disappointment in Store for Tilray (TLRY) Q3 Earnings?

    Investors will focus on pipeline progress and updates when Tilray (TLRY) reports third-quarter results.

    Tilray, Inc. (TLRY) Stock Sinks As Market Gains: What You Should Know

    Tilray, Inc. (TLRY) closed at $90.41 in the latest trading session, marking a -0.3% move from the prior day.

    The Zacks Analyst Blog Highlights: Tilray, Cronos, Canopy Growth, GW Pharmaceuticals and Constellation Brands

    The Zacks Analyst Blog Highlights: Tilray, Cronos, Canopy Growth, GW Pharmaceuticals and Constellation Brands

    Tilray, Inc. (TLRY) Dips More Than Broader Markets: What You Should Know

    In the latest trading session, Tilray, Inc. (TLRY) closed at $120.79, marking a -1.48% move from the previous day.

    Sweta Killa headshot

    Marijuana ETF Enters Bear Territory: What Lies Ahead?

    Despite entering into bear territory, the cannabis ETF is up more than 24% over the past three months and the outlook remains bright.

    Marijuana Stocks Plummet to Record Low: What's Next?

    Legalization has long been considered a boon for the marijuana industry.

    The Zacks Analyst Blog Highlights: Tilray, Coca-Cola, Constellation Brands, Canopy Growth and ETFMG

    The Zacks Analyst Blog Highlights: Tilray, Coca-Cola, Constellation Brands, Canopy Growth and ETFMG

    Neena Mishra headshot

    Canada Legalizes Marijuana: Stocks & ETF in Focus

    Canada legalized recreational pot today but it's "sell the news" event for pot stocks that have seen astronomical gains recently.

    Are Options Traders Betting on a Big Move in Tilray (TLRY) Stock?

    Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.